chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I used to have at most four eczema spots on my body. They usually clear up after four to five days. I have severe eczema flare up after the first dose and it exacerbated further after the second dose. I had over fifty spots on entire my body except the face. My eczema spots were red dots the size of pencil dots in the past but the recent spots after vaccination were different. They were light red dots that radiated out  to about an inch in diameter.  I was given prednisone on 2/22 and it gave me relief. Today I still have those eczema spots that don't seem to clear easily . I do not have over fifty spots but it is about ten spots. I am on my usual course of hydroxyzine and Clobetasol.  I am unsure if it is coincidental or consequential.
Patient reported numbness and tingling within 4 hours of administration.  Received first dose of the Moderna Vaccine and I had a reaction.... Reported that her ear to my chin went numb and my lips and tongue were tingling and it lasted hours!!! It felt like my Bell?s palsy came back.  She reached out to her PCP to ask about whether or not she should get her 2nd vaccine - worried about Bell's Palsy recurring or worsening tongue swelling/tingling.
Myalgia SORENESS IN L ARM/STIFF NECK/SWOLLEN LYMPH NODES/FATIGUE Narrative:
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55-year-old male patient received BNT162b2 (BNT162B2), in Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 55 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "high cholesterol" (unspecified if ongoing). Concomitant medication(s) included: LIPITOR, start date: Jan2020, stop date: 17May2022. The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant) all with onset May2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of covid-19, drug ineffective.  Clinical course: Recurrence of symptoms of sore throat and dry cough. Paxlovid was used as treatment for covid 19. The Hospitalization was not Prolonged. The patient did not received treatment. AE resulted in None of the above. The patient had no Known allergies.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Heart pounded hard that almost shook her whole body; A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events heart pounded hard that almost shook her whole body / heart rate abnormal.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On an unknown date, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) via unknown route for prophylaxis of COVID-19 infection.  On 26 Mar 2021, the patient experienced the event, heart pounded hard that almost shook her whole body.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event, heart pounded hard that almost shook her whole body was unknown.
Hospital Course:  Patient is a 78 y.o. male patient of, CNP with history of essential hypertension diabetes mellitus dyslipidemia history of CVA A-fib status post watchman presented with cough and shortness of breath   Discharge Diagnoses: Covid-19 Virus PNA Acute Hypoxic Respiratory Failure POA Suspected gram positive PNA POA Date of onset of symptoms: 3/31/2023 Symptoms present on admission: Hypoxia and cough Date of covid positive test: 4/1/2023 Imaging: Chest x-ray bilateral lower infiltrates CTA Chest: No PE  Oxygen requirements on admission: Nasal cannula 5 L Current oxygen requirements: 1 L of O2 Medical therapy: remdesivir, steroids, rocephin and doxycycline Expected End of isolation: 4/11/23 Procal elevated, but trended down     Essential hypertension Continue lisinopril and metoprolol  Chronic A-fib status post watchman Currently sinus rhythm not on anticoagulation  Diabetes mellitus not on long-term insulin use Resume home meds   Dyslipidemia Statin  OSA Unable tolerate CPAP
Information has been received from a consumer concerning a 72 year old male who was supposed to received ZOSTAVAX (Oka/Merck) on 10-MAR-2009 was vaccinated with VARIVAX (Oka/Merck) (lot # 660654/0392X). The patient sought unspecified medical attention. No adverse experience reported. No additional information is available.
Pt recv vax on 11/9/98; on same day pt exp daze look, limp, pale color x1 min; pt to E.R.-hypotonic, nonresponsive
?Covid arm? - 8 days after first dose, my arm swelled up, was red, warm to touch, and itchy.
Tdap (Adacel) administered to child age 10 years.  Valid only ages 11-64.  No adverse side effects.  RN will check in NCIR and have a 2nd nurse verify correct vaccine before adm.
14MAR96 PM sl redness on site on rt arm;next AM 15MAR96 site on rt arm red, hard, size of baseball;arm swollen to shoulder, face & eyes swollen;no c/o pain just very itchy @ site;t105 15MAR96, 16MAR96;t104.6 17MAR96, t101 18MAR95;saw MD
Incorrect vaccine given as a booster.  Novavax only EUA for primary series - gave as booster
Five days after receiving the second Pfizer Covid-19 injection, I noticed that I had developed a large red swelling on my left arm where I received my injection. It is slightly itchy and moderately painful.  Overall size is a circle with a 2-3inch diameter.
Chief complaint Hyperglycemia. Possible exacerbation R/T varicella reaction. Rocephin IV given while hosp. D/T cellulitis R arm.  07/31/2007 MR received for DOS 6/1-2/2007.  Child with 12 year hx of type 1 Diabetes on insulin pump presented with high blood sugars (>500) x 1 week.  Pump site had not been changed as needed q 2 days.  Right upper arm swelling where varivax given.    PE (+) for large goose egg sized bump on the posterior aspect of R upper arm with erythema and warmth.  Impression:  Uncontrolled DM1. Dehydration.  Possible skin infection
Pt came to ER c/o chest pain with radiation to right jaw, SOB.  Onset 2 hours prior to arrival.
Systemic: Fainting / Unresponsive-Mild, Additional Details: Patient fainted but did not remember. She stated that she has fainted due to vaccine and blood being drawn (due to needle involving situations). When I came to patient, she became conscious when I tapped her. Pulse was fine. 911 response team came and took her to hospital since she was still stable even though pt felt she was okay.
Started out as itching and redness around injection site.  Reaction spread to larger area on arm just above the elbow and below the back of the shoulder.
Chills, shaking, muscle aches, headache, lightheadedness, fatigue
Muscles pain; Joints pain; This is a spontaneous report from a contactable physician. A 49-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route in the right arm on 25Jan2021 at 10:00 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Medical history of the patient was reported as none. The patient had no known allergies. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route in the left arm on 06Jan2021 at 10:30 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 08:00, the patient experienced muscles pain and joints pain. The events did not result in a visit to doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events muscles pain and joints pain was not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Undiluted Pfizer BioNtech vaccine was administered.  No acute reactions were observed during the 15 minute wait period.
Pericarditis, Costochondritis,  heart palpitations, tingling down left arm and left leg, chest pain, neck pain,  throat tightening, chest tightening, rib pain, headaches for months, neurology eye issues, vertigo,  panic attacks, and anxiety.
Night of vaccine administration - client reports hives; itching all over, eyes, throat itching.
Miscarriage; This is a Spontaneous report from a contactable consumer (patient). This consumer reported information for both mother and fetus. This is the maternal report. A 39-year-old female consumer reported that a 39-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: EL9269), via an unspecified route of administration at left arm on 04Feb2021 14:00 at a single dose for COVID-19 immunization. Medical history included allergies: Penicillin. No other vaccine in four weeks. Concomitant medications included (in two weeks) Prenatal vitamin, colecalciferol (VITAMIN D), folic acid (FOLATE) and sertraline hydrochloride (ZOLOFT 25mg). The patient's last menstrual date was 14Dec2020 and the delivery date was on 17Sep2021 (Gestational period: 8, as reported). An OB exam on 03Feb2021 showed healthy baby at 7w5d- heartbeat detected 152bpm; no abnormalities identified via ultrasound, Labs and hormone levels all within normal ranges. No issues detected. Mother received 1st dose of vaccine 04Feb2021. Per ultrasound on 20Feb2021, fetus stopped growing on 09Feb2021 (8w4d); no heartbeat detected. Miscarriage occurred 22Feb2021. AE resulted in Emergency room/department or urgent care, congenital anomaly (as reported). No treatment was administered. No COVID prior vaccination. Patient not COVID tested post vaccination. The outcome of the event was not recovered.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021225027 fetus case
Injection site redness, pain, swelling lasting Tues-Fri. Symptom onset at 1430 that day included queasiness, headache, hip and chest ache, chilling, hands and feet very warm and red, but no temperature. Took Ibuprofen at approx. 5pm, Tylenol at 8pm, Ibuprofen at midnight. Woke up at 4:15 am Wed and felt fine.
12/11/09 Received H1N1 vaccine late same day developed aching joints. Seen by PMD 2/ 14 - aching joints - mainly hips shoulders, wrists - worse at night. Original D/X Lyme Disease  - R/X doxycycline x 11 days. Symptoms subsided while on meds after completion - aching returned. Saw PMD 1/26 - aching improved not gone. Given R/X for CELEBREX - may not take. No s/s other than aching joints.
Day 1: Shot Friday about 530 PM. Waited 30 minutes+. VERY ITCHY skin within minute or more of injection. Skin itched all over, but no rash, no other symptoms. Took usual aspirin & Tylenol before bed. Also began probiotics and elderberry/zinc/C supplements recommended in Covid handout.   That night: Slept on other arm, when rolled over in early AM, hurt to press on shot arm.   Day 2: Woke up hay feverish - sinuses completely blocked but could breathe through mouth, so airway OK. Moderate headache, all over muscle aches. Took usual aspirin & Tylenol. Skin still itches all over. Took a Zyrtec. Sinuses cleared, muscles and head aches went from moderate to mild, skin itch also from moderate to mild. Took usual aspirin & Tylenol before bed.   Day 3: Woke up with sinuses partially blocked and sneezing. Mild headache and muscle aches. Took usual aspirin & Tylenol, and when sinuses wouldn't clear on sitting up and blowing and kept sneezing, took another Zyrtec.   Day 4:  Sinuses draining so I'm going to try to do without Zyrtec. Body still very achy so taking usual aspirin & Tylenol.   Day 5 and beyond: Symptoms gradually subsided without further Zyrtec. Higher than normal tiredness persisted longer than aches and hay fever symptoms. Overall, much milder reaction than I had to a flu vaccine many years earlier, so I'm pleased, but felt VAERS should have complete information.
administered with vaccine which was beyond the use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered with vaccine which was beyond the use date) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 067F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 10-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered with vaccine which was beyond the use date). On 10-Dec-2021, EXPIRED PRODUCT ADMINISTERED (administered with vaccine which was beyond the use date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Pharmacist reports that they administered the Moderna Covid-19 vaccine which was beyond the use date to 14 patients in a nursing home.  Pharmacist's stated that the beyond the use date is 09Dec2021 at 10:00PM  No concomitant medication were provided No treatment details were provided Date the vial was initially stored in the refrigerator - 28Nov2021
Developed small hives over body and itching within 12 hrs of receiving KINRIX (DTaP and IPV), MMR #2 and VARIVAX #2.
This spontaneous report as received from a registered nurse regarding 3 patients of unknown demographics. There was no information about concurrent condition and historical medication. On 22-JUN-2016, 06-JUL-2016 and 11-JUL-2016 the patients were vaccinated with PNEUMOVAX 23, lot # K012424, expiration date- 05-JUN-2016. After the 3rd dose it was realized that the vaccine was expired. No known complaints were received from any of the patients. No treatment was given. No PQC (product quality complaint) was involved. The outcome of the event was unknown. Additional information has been requested.
The 12 year-old patient received a pediatric first dose of the pfizer vaccine for patients age 5-11 rather than an adult dose for patients 12 years and older.  No side effects or symptoms reported from guardian. The patient will receive adult Pfizer vaccine at 21 days as recommended by Pfizer.
A non-serious spontaneous report of diagnosis of influenza after FLUMIST has been received from a physician concerning a seven-year-old female, subsequent to FLUMIST. Neither relevant medical history nor concomitant medications have been reported for this patient. On 30-Aug-2010, the patient received FLUMIST. On 15-Feb-2011, a rapid Flu test was performed and the patient tested positive and diagnosed with influenza. The patient was presented with a congestive cough, a clear runny nose and a poor appetite. All the symptoms were resolved. The outcome of the event was resolved.
This spontaneous report was received from a pharmacist refers to multiple unspecified patients of unknown gender and age. Information regarding the patients' medical history, concurrent condition, drug reaction/allergies and concomitant therapy were not provided. On unknown dates, the patients were vaccinated with improperly stored PROQUAD (lot # L027634, expiry date: 21-JAN-2017) (incorrect product storage). No adverse effect were reported. This is one of the three reports received from the same reporter. Additional information has been requested.
Information has been received from a registered nurse concerning an 11 year old Caucasian male with no past medical history who on 10/25/95 was vaccinated with a first dose of varicella virus vaccine live (SC), in the left arm. There was no illness at the time of vaccination. On 6/20/03 the patient developed a fever and fluid filled vesicles, about 20 to 30. The patient was diagnosed with chicken pox. The patient sought medical attention. The patient was treated with acyclovir 800 mgm QID for 5 days, acetaminophen and colloidal oatmeal. The symptoms resolved in 5 to 7 days. it was reported that the patient had a positive titer for varicella IgM. It was noted that the patient had been exposed to varicella many times when he was younger but never developed varicella. No further information is expected.
rt arm w/in 24hrs of vax pt exp swelling of shoulder, back upper, arm down to elbow;hot, red, painful to touch; pt full ROM
SWELLING OF THE UPPER LIP  (Lip swelling,  Lip swelling)  FACIAL SWELLING  (Facial swelling,  Swelling face) SORE ARM  (Pain in arm,  Pain in extremity) This spontaneous report received from a patient  (health care professional)  concerned a female of unspecified age. The patent's height,  and weight were not reported. The patient's concurrent conditions included cat allergy,  food allergy,  and dye allergy. The patient received covid-19 vaccine ad26.cov2.s  (suspension for injection,  route of admin not reported,  batch number:  Unk) dose was not reported,  administered on 12-MAR-2021  10:35 for prophylactic vaccination.  The batch number was not reported and has been requested.  No concomitant medications were reported. On 12-MAR-2021,  after receiving the vaccine,  the patient experienced sore arm,  swelling of the upper lip and facial swelling. The action taken with covid-19 vaccine ad26.cov2.s was not applicable.  The patient had not recovered from sore arm,  swelling of the upper lip,  and facial swelling.  This report was serious  (Life Threatening) .  Version 1 created to amend previously reported information on 12-MAR-2021.  Upon review following information was amended:  The events sore arm,  swelling of the upper lip,  and facial swelling upgraded to serious with seriousness criteria as Life threatening.
Very sore arm was only beginning symptom.  Then 2-3 days later I began having nausea, and lack of appetite and began spotting (as if my period was beginning).  Light pink to red discharge that went away after 3 days.  My period was not due until the 19th of this month.  I developed a small headache that lasted approximately 12 days coming and going (rarely have headaches in past).  My hands have been achy like I have arthritis (which I've never experienced this).  Also, diarrhea and disturbed sleep pattern.  My period is now late.  Its 4.23 and no symptoms of period or premenstrual syndrome.
THE PATIENT RECIEVED A LARGE BRUSE EXSTENDING BELOW THE ELBOW AND ALMOST THE FULL CIRCUMFERANCE OF THE ARM. AT LEASE 12 INCHES
Pt received third Prevnar on 03/12/2002. Developed hives on 03/14/2002. Seen 03/18/2002 with urticaria and target lesions on face, trunk and extremities.
Mobile clinic provider (myself, APRN) was in bathroom inside church. While I was in bathroom, the MA checked in a patient who stated they wanted their flu vaccine. The MA asked if pt wanted COVID-19 booster and they said no, as they already received that. Pt stated he only wanted flu vaccine. MA got consent forms out and had pt fill out and sign consent form for flu. Provider walked into mobile clinic with pt already checked in and consent form completed/signed for influenza vaccine. Provider got appropriate flu vaccine for age out of vaccine cooler and gathered all materials. Prior to administering vaccine. I asked him if he wanted flu vaccine information sheets and he declined, stating he didn't need that. Vaccine administered and pt left. Provider went to document vaccine in System and there was an error message that the vaccine was already administered previously. Noted in his immunization record that he recieved FLUAD on 10/4/22. Pt was called and notified he had received a second dose of influenza. He stated he wanted his COVID-19 booster and not flu vaccine. Apologized to pt for medication error and that we would call him back with clarification on when he could get his COVID-19 booster.
Covid19 breakthrough.  1st vaccine received on 01/26/2021.  50 y/o with PMHX of CADASIL dementia, bradycardia, depression, Dysthymic disorder, memory loss, vascular dementia, G-tube and non-verbal per baseline presents to ED via EMS from a HCF and Rehab with cough, abnormal CXR, decreased appetite and fever x1 day.  CXR with stable moderate patchy opacities involving left lower lobe likely infectious/inflammatory.  Pt on O2 2L NC sats 98%, febrile per rehab reports.  Pt started on IV steroids/ABX and Remdesivir.
Headache, Myalgia, Fever,  arm discomfort, itching below the injection site, "did not feel well" Narrative: Fever blister emerged in mouth and nose on June 13 and resolved on June 24
The wrong covid vaccine was administered.  The patient was wanting the bivalent vaccine and received the regular covid vaccine.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 12Sep2022 as dose 4 (booster), single (Lot number: GH9702) at the age of 38 years, in right arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 06Apr2021 as dose 1, single (Lot number: ER8729), on 27Apr2021 as dose 2, single (Lot number: EW0167) and on 02Dec2021 as dose 3 (booster), single (Lot number: 301558H) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing). The patient's concomitant medications were not reported. Patient had no known allergies. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of vaccination failure, covid-19 including PAXLOVID given on 05Jan2023 to 09Jan2023.  No follow-up attempts are possible. No further information is expected.
rougher reactions to the second dose compared to the first; had to take off work the next day; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of   in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form.            Concomitant product use was not provided by the reporter.  No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not applicable
Patient presented to the ED on 5/3/2021 for migraine with aura. Patient had second covid vaccination dose on 5/13/2021. On 6/3/2021 patient was hospitalized for PROM, status post spontaneous vaginal delivery complicated by shoulder dystocia, normocytic anemia secondary to acute blood loss. These visits are within 6 weeks of receiving COVID vaccination.
Patient states approximately 1 and 1/2 weeks after receiving the vaccine he developed a painful, itchy rash on the right side of his body on his elbow, knee, and ankle. Patient stated looked like eczema type rash.
This spontaneous report was received from a researcher refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 13-MAR-2019 the patient was vaccinated with improperly stored ROTATEQ lot # R016790 (expiry date: 20-APR-2020), orally for prophylaxis. It was stated that the vaccine underwent a temperature excursion of -1.8 degree Celsius for 33 minutes; Previous temperature excursion included 11.3 degree Celsius for 30 minutes. The call was because of a "data logger". Dose administered after initial warm excursion. No adverse effects reported.